Annual Report 2024

Harish Manikandan lives with obesity in Chile. Harish maintains an active lifestyle in the bustling city of Santiago and, amid his daily duties as head chef at a restaurant, finds tranquility on his electric bike, commuting to work, cycling in the city’s expansive parks and cruising Santiago in the evenings when the temperature cools and the traffic is light.

Novo Nordisk employees Jayashri Seshadri and Merlin Till Witte in our laboratories in Måløv, Denmark. Jayashri and Merlin are part of a transformational research unit working to improve the lives of people living with serious chronic diseases through innovative stem cell-based therapies.

Participants at the 2024 World Panna Championships in Copenhagen, Denmark. ‘Panna’ is an increasingly popular type of street football, and the Pannahouse organisation champions physical and mental health, cultural understanding and robust communities within urban youth culture. Photo: UP MEDIA.

Zilda Maria da Silva was terrified when diagnosed with type 2 diabetes age 19, especially given her father’s early death from diabetes complications. 15 years later, Zilda started insulin treatment to prolong her life. Today, she lives in São Paulo, Brazil and is training for a marathon at 71 years old.

Main menu

Value creation

We focus on creating lasting value for society and our business with a strong commitment to financial, environmental and social responsibility. Following the Novo Nordisk Way, we are dedicated to delivering long-term value for people living with serious chronic diseases, our employees, partners, shareholders and society at large.

Scroll to explore

Resources

Research and development

Manufacturing

Distribution

Patients

Added 13,030 employees bringing Novo Nordisk’s total workforce to 77,349, while supporting job-creation amongst our suppliers Invested more than DKK 52 billion in R&D Invested more than DKK 129 billion – mainly in production capacity – to meet demand for current and future products Reached more than 45.2 million people living with serious chronic diseases Reached 8.4 million vulnerable people living with diabetes

Ownership structure

The Novo Nordisk Foundation awards grants in three strategic areas: health, sustainability and the life science ecosystem. In 2024, more than DKK 10 billion were awarded.